Novo Holdings A/S - GALERA THERAPEUTICS INC ownership

GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 41 filers reported holding GALERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of GALERA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$6,552,000
+4.1%
2,100,000
-14.6%
0.51%
+21.9%
Q1 2023$6,295,094
+71.8%
2,459,0210.0%0.42%
+81.2%
Q4 2022$3,663,941
-14.4%
2,459,0210.0%0.23%
+12.3%
Q3 2022$4,279,000
+33.8%
2,459,0210.0%0.20%
+29.9%
Q2 2022$3,197,000
-45.4%
2,459,0210.0%0.16%
-49.2%
Q1 2022$5,852,000
-48.2%
2,459,0210.0%0.31%
-42.1%
Q4 2021$11,287,000
-43.3%
2,459,0210.0%0.53%
-48.2%
Q3 2021$19,918,000
-17.6%
2,459,0210.0%1.03%
-3.9%
Q2 2021$24,172,000
+11.4%
2,459,0210.0%1.07%
+19.6%
Q1 2021$21,689,000
-28.4%
2,459,021
-16.9%
0.90%
-31.0%
Q4 2020$30,271,000
-1.8%
2,959,021
-13.2%
1.30%
-15.2%
Q3 2020$30,818,000
+26.6%
3,409,0210.0%1.53%
-2.6%
Q2 2020$24,340,000
-24.8%
3,409,0210.0%1.57%
-27.3%
Q1 2020$32,386,000
-27.8%
3,409,0210.0%2.16%
-25.2%
Q4 2019$44,863,0003,409,0212.89%
Other shareholders
GALERA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 3,083,712$40,582,0002.92%
Novo Holdings A/S 3,409,021$44,863,0002.89%
NEA Management Company, LLC 4,362,986$57,417,0002.72%
SPHERA FUNDS MANAGEMENT LTD. 471,439$6,204,0000.51%
RA Capital Management 1,054,178$13,873,0000.42%
Rock Springs Capital Management LP 500,000$6,580,0000.21%
Tekla Capital Management LLC 416,666$5,483,0000.21%
Blackstone Inc. 1,678,984$22,095,0000.14%
Perceptive Advisors 325,000$4,277,0000.08%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,300,000$17,108,0000.04%
View complete list of GALERA THERAPEUTICS INC shareholders